Identification of COVID-19 patients with high Risk of mortality at ICU admiSsion - IRIS-study
- Funded by Netherlands Organisation for Health Research and Development (ZonMW)
- Total publications:0 publications
Grant number: 1.043E+13
Grant search
Key facts
Disease
COVID-19Start & end year
20202022Known Financial Commitments (USD)
$257,165.49Funder
Netherlands Organisation for Health Research and Development (ZonMW)Principal Investigator
Prof Dr NF de KeizerResearch Location
NetherlandsLead Research Institution
Nationale Intensive Care EvaluatieResearch Priority Alignment
N/A
Research Category
Epidemiological studies
Research Subcategory
Disease transmission dynamics
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Not applicable
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Other
Occupations of Interest
Unspecified
Abstract
Project description Deciding which COVID-19 patients will benefit most from intensive care unit (IC) treatment is an important societal issue. New COVID-19 patients are admitted daily. Care for non-COVID-19 patients must also continue. The pressure on IC capacity became very high during the COVID-19 peak in the spring of 2020, which could be repeated in the next wave. Research and expected outcomes This study looks at patient characteristics that indicate an extremely long IC admission or a very high risk of death for the patient. Intensivists, other specialists, the patient and family members can use this knowledge to jointly make informed decisions about the usefulness of an IC admission. The research uses three data registers ( NICE foundation , CovidPredict and Vektis ). Together, the registries include all IC patients in the Netherlands, including detailed and long-term outcome information for COVID-19 patients. Analyzes are done by means of statistical and machine learning techniques.